Beckwith-Wiedemann syndrome (BWS) (OMIM 130650) is a disease of prenatal overgrowth, congenital malformations, and predisposition to cancer. The syndrome was independently described by J.B. Beckwith, an American pathologist, at the annual meeting of the Western Society for Pediatric Research in 1963  and H.R. Wiedemann, a German pediatrician, in 1964 . This disease was initially referred to as the EMG syndrome for its most prominent clinical features that distinguished the syndrome from other congenital malformations: exomphalos, macroglossia, and gigantism.
KeywordsCancer Screening Adrenocortical Carcinoma Neonatal Hypoglycemia Abnormal Methylation Adrenal Hypoplasia Congenita
- 1.Beckwith JB (1963) Extreme cytomegaly of the adrenal fetal cortex, omphalocele, hyperplasia of kidneys and pancreas, and Leydig cell hyperplasia – another syndrome? Paper presented at annual meeting of the Western society for pediatric research, Los Angeles, Nov 11Google Scholar
- 2.Wiedemann HR (September 1964) Familial malformation complex with umbilical hernia and macroglossia – a “new syndrome?” (in French). J de génétique humaine 13:223–232Google Scholar
- 11.Weksberg R et al (2010) Beckwith-Wiedemann Syndrome. Eur J Hum Genet 18:8–14Google Scholar
- 15.Choyke PL et al (1998) Nonmalignant renal disease in pediatric patients with Beckwith-Wiedemann syndrome. AJR 1711:733–737Google Scholar
- 18.DeBaun M, Tucker MA (1998) Cancer during the first four years of life in children from the Beckwith Wiedemann Syndrome Registry. J Pediatr (132):398–400Google Scholar
- 24.DeBaun M et al (1996) Screening for Wilms’ tumor in children with high-risk congenital syndromes: considerations for, an intervention trial. Med Pedia Oncol 27:15421Google Scholar